Board of Directors

Timothy Mills, Chairman is currently a Managing Director at Sanderling Ventures in San Mateo CA. He has over twenty-five years of experience in biomedical research, corporate management and venture investing.

Matthew Jenusaitis is currently the president and CEO of OCTANe. Prior to OCTANe, he served in numerous executive marketing and general management positions. Matthew was the President of ev3 Neurovascular prior to the Covidien acquisition.

Rob Abrams, President and CEO – see management team